Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$254M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Tariq Musa | Dec 18, 2024 | Sell | 116 | $34.85 | $4,000 |
| Tariq Musa | Dec 13, 2024 | Sell | 2,320 | $35 | $81,000 |
| Joyce Meghan V. | Dec 2, 2024 | Sell | 100 | $35.9 | $3,600 |
| Kalia Kumud | Nov 18, 2024 | Sell | 7,000 | $29.246 | $200,000 |
| Joyce Meghan V. | Nov 13, 2024 | Sell | 2,896 | $29.9017 | $87,000 |
| CLARK IAN T | Nov 12, 2024 | Sell | 7,242 | $29.4351 | $210,000 |
| CLARK IAN T | Nov 12, 2024 | Sell | 1,076 | $29.5172 | $32,000 |
| Joyce Meghan V. | Jun 4, 2024 | Sell | 100 | $27.87 | $2,800 |
| Kalia Kumud | Mar 18, 2024 | Buy | 2,187 | $17.8156 | $39,000 |
| Joyce Meghan V. | Mar 4, 2024 | Sell | 100 | $19.05 | $1,900 |
| Joyce Meghan V. | Dec 4, 2023 | Sell | 100 | $26.34 | $2,600 |
| Kalia Kumud | Dec 1, 2023 | Sell | 5,800 | $26.3714 | $150,000 |
| Kalia Kumud | Sep 12, 2023 | Sell | 2,125 | $32.59 | $69,000 |
| Joyce Meghan V. | Sep 5, 2023 | Sell | 100 | $35.01 | $3,500 |
| Joyce Meghan V. | Jun 15, 2023 | Sell | 2,766 | $37.55 | $100,000 |
| Kalia Kumud | Jun 9, 2023 | Buy | 2,231 | $32.6821 | $73,000 |
| Kalia Kumud | Jun 9, 2023 | Buy | 750 | $32.779 | $25,000 |
| Eltoukhy Helmy | Mar 15, 2023 | Buy | 8,600 | $26.1544 | $220,000 |
| Eltoukhy Helmy | Mar 14, 2023 | Buy | 84,452 | $26.3334 | $2.2M |
| Talasaz AmirAli | Mar 14, 2023 | Buy | 8,500 | $26.3972 | $220,000 |
| Talasaz AmirAli | Mar 14, 2023 | Buy | 4,250 | $26.3972 | $110,000 |
| Talasaz AmirAli | Mar 13, 2023 | Buy | 27,813 | $26.0392 | $720,000 |
| Talasaz AmirAli | Mar 13, 2023 | Buy | 13,906 | $26.0392 | $360,000 |
| Talasaz AmirAli | Mar 13, 2023 | Buy | 12,187 | $24.7795 | $300,000 |
| Talasaz AmirAli | Mar 13, 2023 | Buy | 6,094 | $24.7795 | $150,000 |
| Kalia Kumud | Mar 3, 2023 | Sell | 6,500 | $31.9179 | $210,000 |
What's the latest insider transaction for Guardant Health?
The most recent insider transaction for Guardant Health was conducted by Tariq Musa, who sold 116 shares on December 18, 2024 at a price of $34.85 per share.
Which insider bought the most GH stock over the last two years?
Eltoukhy Helmy has bought the most GH stock in the last 2 years, with a total value of $2.4M.
Which insider has sold the most GH stock over the last two years?
Kalia Kumud has sold the most GH stock in the last 2 years, with a total value of $630,000.
What is the total value of insider transactions for Guardant Health (GH) in the last 2 years?
According to our estimates, the total value of insider transactions for Guardant Health in the last 2 years is positive, amounting to $3.3M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Guardant Health's market confidence?
Over the last 2 years, insider transactions for Guardant Health have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
